SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001493152-18-012354
Filing Date
2018-08-20
Accepted
2018-08-20 16:44:04
Documents
52
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 form10-qa.htm 10-Q/A 799498
2 ex10-2.htm EX-10.2 45891
3 ex31-1.htm EX-31.1 19659
4 ex31-2.htm EX-31.2 11771
5 ex32-1.htm EX-32.1 8467
6 ex32-2.htm EX-32.2 8286
  Complete submission text file 0001493152-18-012354.txt   3108633

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE prph-20170331.xml EX-101.INS 388270
8 XBRL SCHEMA FILE prph-20170331.xsd EX-101.SCH 38081
9 XBRL CALCULATION FILE prph-20170331_cal.xml EX-101.CAL 53077
10 XBRL DEFINITION FILE prph-20170331_def.xml EX-101.DEF 108944
11 XBRL LABEL FILE prph-20170331_lab.xml EX-101.LAB 255428
12 XBRL PRESENTATION FILE prph-20170331_pre.xml EX-101.PRE 187197
Mailing Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901
Business Address 621 N. SHADY RETREAT ROAD DOYLESTOWN PA 18901 2153450919
ProPhase Labs, Inc. (Filer) CIK: 0000868278 (see all company filings)

IRS No.: 232577138 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-21617 | Film No.: 181028645
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1